logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for global professionals · Wednesday, February 18, 2026 · 893,512,072 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Companies News  •••  Topics  •  Countries  •  U.S. States

Novo Nordisk Revenues News Monitoring

  • Published on 21:16 GMT

    Levi & Korsinsky To Lead Novo Nordisk Investor Class Action

    By Carla Baranauckas ( February 18, 2026, 4:08 PM EST) -- Levi & Korsinsky LLP has been appointed lead counsel in a proposed securities class action accusing Novo Nordisk A/S of misleading investors about its 2025 revenue outlook, after a New …

    Source: Law360 - Pending
  • Published on Feb 17, 2026

    Pricing and reimbursement delays continue to impact biopharma revenue streams

    Delays in obtaining pricing and reimbursement (P&R) have been identified as key hurdles holding back the pharmaceutical industry, according to market analysis. This trend is highlighted through responses to a survey taken from GlobalData’s State of the …

    Source: Pharmaceutical Technology - Neutral
  • Published on Feb 16, 2026

    Novo Nordisk's New Diabetes Drug Outshines Ozempic: Is The Stock a Buy?

    Key Points Ozempic has been one of Novo Nordisk's (NYSE: NVO) main growth drivers for several years now and has practically become a household name. However, the Denmark-based drugmaker has lost ground to its biggest competitor, Eli Lilly (NYSE: LLY), …

    Source: Nasdaq - Neutral
  • Published on 14:31 GMT

    Exclusive: NHS must keep medicine clawback down or lose investment, says weight-jab boss

    Wednesday 18 February 2026 2:27 pm  |  Updated:  Wednesday 18 February 2026 2:28 pm Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on LinkedIn WhatsApp Share on WhatsApp Email Share on Email Novo Nordisk's control of the weight-loss …

    Source: City A.M. - Center-right
  • Published on 13:17 GMT

    Weight-loss drugs reshape Brazil’s restaurant industry

    Strong consumer uptake of weight-loss injections—and the buzz surrounding them on social media—has helped drive changes in restaurant business models. Smaller portions, higher-protein options, and non-alcoholic cocktails are gaining ground as …

    Source: Valor International - Neutral
  • Published on 19:39 GMT

    Novo expands injectable Wegovy offering with European higher dose approval

    The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the drugmaker as it looks to recover competitiveness in the weight loss market.  The authorisation means a new 7.2mg once-weekly maintenance …

    Source: Pharmaceutical Technology - Neutral
  • Published on 18:44 GMT

    Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug

    Eli Lilly has been scouting for drugs to follow the trail blazed by its blockbuster cardiometabolic medicines. Its latest pipeline-building deal has the pharmaceutical company paying $100 million for rights to a clinical-stage CSL Limited drug addressing …

    Source: MedCity News - Neutral
  • Published on 16:10 GMT

    Five stock picks for 2026

    For many years, a New Zealand media publication has asked local sharebroking and wealth management firms to nominate five NZX companies they think will do well over the year ahead. The format has changed slightly over recent years – participants to the …

    Source: Newsroom - Neutral
  • Published on 14:09 GMT

    Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness ...

    Growing Adoption of Growth Hormone Therapy, Expanding Estrogen Replacement Programs, and Government-Backed Rare Disease Initiatives Accelerate Turner Syndrome Market Growth. Austin, United States, Feb. 18, 2026 (GLOBE NEWSWIRE) — Turner Syndrome Market …

    Source: Business Upturn - Neutral
  • Published on 12:37 GMT

    Lurpak-maker Arla sees lower dairy prices and boost from protein products

    By Louise Rasmussen Impact of Milk Production Increase COPENHAGEN, Feb 18 (Reuters) - Denmark-based Arla expects a global milk surplus to drive down dairy prices this year, giving a fresh boost to demand for high-protein products such as whey and cottage …

    Source: Global Banking & Finance Review - Neutral
  • Published on 02:16 GMT

    Lawsuit accuses Cigna PBM of ‘demanding kickbacks’ from drug maker

    The Plumbers’ Welfare Fund has filed a federal lawsuit accusing Express Scripts, its parent company Cigna, and a subsidiary of orchestrating a multibillion-dollar scheme that allegedly inflated prescription drug costs while diverting rebates owed to …

    Source: Insurancenewsnet - Pending
  • Published on Feb 17, 2026

    The Great AI Repricing

    Investors are trying to recalibrate. Business models will change with AI. Some will thrive. Others will discover that their moat was more decorative than defensive. Analysts have drawn parallels to the early pandemic era, when entire sectors were abruptly …

    Source: Market Screener - Neutral
  • Published on Feb 13, 2026

    Biocon aims for revenue surge with rollout of generic weight-loss drugs

    Audio By Carbonatix By Rishika Sadam Feb 13 (Reuters) – Biocon is aiming for high-double-digit percentage revenue growth as the Indian pharmaceutical firm prepares to launch generic versions of weight-loss drugs globally even as it remains cautious about …

    Source: SRN News - Center-right
  • Published on Feb 17, 2026

    Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)

    Barclays analyst James Gordon CFA maintained a Buy rating on Galderma Group AG yesterday and set a price target of CHF195.00. Gordon CFA covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Galderma Group AG, and GlaxoSmithKline. …

    Source: Markets Insider - Neutral
  • Published on Feb 16, 2026

    Weight-Loss Pills Mark a Turning Point for Pharma Industry

    The global pharmaceutical industry is entering a pivotal phase in obesity therapeutics as companies accelerate the transition from injectable GLP-1 drugs to oral weight-loss treatments, a shift expected to significantly expand patient access, alter …

    Source: World Pharma Today - Neutral
  • Published on Feb 16, 2026

    Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

    As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock’s all-time high. Retail sentiment has turned decisively bullish following the company’s Q4 2025 earnings beat, with Reddit’s sentiment score climbing …

    Source: 24/7 Wall St. - Neutral
  • Published on Feb 16, 2026

    Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Month’s 48% Selloff

    Hims & Hers Health (NYSE:HIMS) has crashed 47.96% over the past month, falling from $31.32 on January 14 to $16.30 as of February 13. Yet Wall Street analysts still see the telehealth platform reaching an average price target of $29.96, implying 84% …

    Source: 24/7 Wall St. - Neutral
  • Published on Feb 16, 2026

    Eli Lilly builds orforglipron cache to avoid previous GLP-1RA shortages

    In a bid to avoid previous shortages of injectable glucagon-like peptide-1 receptor agonists (GLP-1RAs), Eli Lilly has already started to assemble a stockpile of its oral weight loss drug orforglipron. In its 2025 annual report, published in February 2026, …

    Source: Pharmaceutical Technology - Pending
  • Published on Feb 16, 2026

    From Nvidia to Bitcoin: The 10 Best Stocks to Buy in 2026 — And Why

    The global economy is being reshaped by artificial intelligence, rearmament, weight-loss drugs, and the institutionalisation of crypto. Here are ten investments — across seven industries — that we believe offer the strongest risk-adjusted returns for the …

    Source: European Business Magazine - Indeterminate

05 days 06:31:57

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
search news using your own keywords. There are 893,512,072 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Companies A-Z >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 02/12/2026

World Media Directory >

Companies Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Companies Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Company News Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2026 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy · Cookie Settings

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.